Related Experiment Video
Updated: Sep 20, 2025
Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
[Cognitive Dysfunction of Pediatric Moyamoya Disease]
1Department of Neurosurgery, Institute of Science Tokyo.
Insights
Moyamoya disease can cause cognitive issues in children, impacting working memory and school performance. Early assessment and lifelong support are vital for affected pediatric patients.
Area of Science:
- Neurology
- Pediatrics
- Cognitive Science
Background:
- Moyamoya disease is a rare cerebrovascular disorder affecting children and young adults.
- Cognitive dysfunction, particularly working memory decline, is common in pediatric moyamoya disease, even without overt stroke.
- This decline is linked to altered blood flow and brain microstructure in specific lobes.
Purpose of the Study:
- To highlight the prevalence and characteristics of cognitive dysfunction in pediatric moyamoya disease.
- To emphasize the importance of assessing educational needs alongside neurological symptoms.
- To stress the necessity of long-term care and knowledge transfer for future healthcare providers.
Main Methods:
- Review of existing literature on moyamoya disease and cognitive function in children.
- Analysis of clinical observations regarding cognitive deficits and their impact on learning.
- Discussion of surgical outcomes and persistent cognitive challenges.
Main Results:
- Cognitive dysfunction, especially in working memory, affects a significant portion of children with moyamoya disease.
- Bypass surgery may improve certain cognitive domains like visual-motor skills, but deficits can persist.
- Educational impact and the need for school support are critical considerations.
Conclusions:
- Pediatric moyamoya disease requires comprehensive management addressing both neurological and educational aspects.
- Lifelong support strategies must be developed and communicated to ensure continuity of care.
- Educating future healthcare providers is essential for sustained patient well-being.
Abstract:
Moyamoya disease is rare and affects children and young adults. A substantial proportion of children with this disease experience cognitive dysfunction in some domains even in the absence of ischemic or hemorrhagic stroke. A characteristic feature is a decline in working memory, which is believed to be associated with reduced blood flow and disrupted microstructure in the frontal and parietal lobes. However, the involvement of the temporo-parietal-occipital lobes has also been reported. While successful bypass surgery can improve cognitive decline in some domains, especially the visual-motor processing ability, some patients still suffer from cognitive decline, which negatively affects school learning. As a primary physician of pediatric patients with moyamoya disease, it is essential to assess not only neurological symptoms but also their educational situation and need for support at each school stage. Furthermore, since children with moyamoya disease will have a long life after initial treatment, it is crucial to transmit our knowledge and current challenges to healthcare providers in the next generation to ensure appropriate support throughout the patients' lives.
